Fumaric Aciduria: an Overview and the First Brazilian Case Report

Total Page:16

File Type:pdf, Size:1020Kb

Fumaric Aciduria: an Overview and the First Brazilian Case Report J Inherit Metab Dis (2010) 33:411–419 DOI 10.1007/s10545-010-9134-2 ORIGINAL ARTICLE Fumaric aciduria: an overview and the first Brazilian case report Gabriella Allegri & Marcia J. Fernandes & Fernanda B. Scalco & Patricia Correia & Ruth E. Simoni & Juan C. Llerena Jr & Maria L. Costa de Oliveira Received: 18 January 2010 /Revised: 5 May 2010 /Accepted: 12 May 2010 /Published online: 15 June 2010 # SSIEM and Springer 2010 Abstract Fumaric aciduria is a rare metabolic disease, Abbreviations with 40 cases reported so far. Fumarase deficiency leads AICAR 5-aminoimidazole-4-carboxamide ribotide mainly to brain abnormalities, developmental delay, and AMP adenosine monophosphate great accumulation of fumaric acid in urine. This work AS argininosuccinase presents the first case of fumaric aciduria described in ASL adenylosuccinate lyase Brazil, which presented with some interesting clinical ASS argininosuccinic synthetase and biochemical findings such as colpocephaly, hepatic AST aspartate aminotransferase alterations, and marked metabolic acidosis since birth. CPSI carbamoylphosphate synthetase I. Common findings were ventriculomegaly, hypotonia, and FAH fumarylacetoacetate hydrolase microcephaly. Biochemically, besides the high urinary FAICAR 5-formaminoimidazole-4-carboxamide ribotide fumaric acid excretion, atypical elevation of plasma FH fumarate hydratase citrulline, tyrosine and methionine levels were also GD glutamate dehydrogenase observed. In order to show all features and variants of 4-HPPD 4-hydroxy-phenylpyruvate dioxygenase fumaric aciduria, literature data of 40 patients was IMP inosine monophosphate reviewed and compared with the case reported here. MAI maleylacetoacetate isomerase Findings in all these patients demonstrate that this ME malic enzyme disorder does not yet have its phenotype completely MDH malate dehydrogenase defined; it is important that more patients be described. OT ornithine transcarbamoylase PC pyruvate carboxylase PDHC pyruvate dehydrogenase complex SAICAR 5-aminoimidazole-(N-succinylcarboxiamide) Communicated by: Jan Smeitink ribotide SDH succinate dehydrogenase Competing interest: None declared. TAT tyrosine aminotransferase G. Allegri (*) : M. J. Fernandes : F. B. Scalco : R. E. Simoni : M. L. C. de Oliveira Laboratório de Erros Inatos do Metabolismo (LABEIM), Departamento de Bioquímica, Instituto de Química, Introduction Universidade Federal do Rio de Janeiro (UFRJ), Cidade Universitária, Ilha do Fundão, Centro de Tecnologia, Fumaric aciduria, an autosomal recessive disorder, is bloco A, 536 C, 21941 900 Rio de Janeiro, Brasil caused by deficiency of the enzyme fumarate hydratase e-mail: [email protected] [fumarase (FH)]. The first patient with fumarase deficiency : (OMIM 136850), presenting with lethargy, microcephaly, P. Correia J. C. Llerena Jr and hypotonia combined with high urinary fumaric acid Centro de Genética Médica, Instituto Fernandes Figueira, FIOCRUZ, excretion, was described by Zinn et al. (1986). Fumaric Rio de Janeiro, Brasil aciduria, however, had already been reported in 1983 by 412 J Inherit Metab Dis (2010) 33:411–419 Whelan et al in a couple of siblings (Whelan et al 1983). sutures, hooked nose, micrognathia, camptodactyly of the Fumaric aciduria is characterized by massive excretion of fifth finger, single transverse palmar crease on the left hand fumaric acid in urine. Other metabolites may also be and postaxial polydactyly on the right hand. Immediately altered in body fluids: Krebs cycle intermediates, other after birth and during the following 17 days, she presented dicarboxylic acids (suberic, adipic), and succinylpurine with hypoglycemic episodes difficult to control (glucose: derivatives. The disease is considered rare, since in the 20–40 mg/dl). Laboratory exams, performed during one of last 27 years, only 40 cases have been reported in the these episodes, showed lactic acidemia (4.0 µmol/ml; N: literature. However, a higher frequency can be observed 0.7–2.5 µmol/ml), mild hyperammonemia,– and marked - at the border of northern Arizona and southern Utah, metabolic acidosis (pH 7.20; pCO2 25.1 mmHg; HCO3 USA. This is probably due to a founder effect in closed, 9.6 mEq/L; BE -17.5 mEq/L). Neurologic exam, per- religious polygamist communities living in these regions, formed at 4 days of life, showed incomplete Moro reflex, among which marriage between relatives seems to be posture of limbs flexion, reduced axial tonus, and frequent (Kerrigan et al 2000,Szep2007). Fumaric slightly elevated appendicular tonus. At 6 days of life, aciduria is classified into the group of disorders that antibiotics were administered for one week due to involve metabolic energy. In this group are included suspicion of sepsis. On the seventh and 25th days, two mitochondrial disorders that may interfere in embryophe- samples of urine and one of plasma were collected and tal development, leading to developmental delay, seizures, sent for inborn errors of metabolism (IEM) screening. motor dysfunction, and alterations in other organ systems, Amino acid analyses were carried out on a Biochrom 20 especially liver, kidney, and blood cells (Saudubray et al (Biochrom Ltd., Cambridge, UK) amino acid analyzer. 2006; Filiano 2006). Sample preparation and analysis were performed accord- FH (E.C. 4.2.1.2) catalyzes the stereospecific and ingtothemanufacturer’s standard protocols. General reversible hydration/dehydration of fumarate to S-malate. aminoaciduria was observed and some plasma amino This enzyme is homotetrameric, iron-dependent, and acids were also altered (Table 1). Urinary organic acid thermostable. It exists in two isoforms, mitochondrial and analyses by gas chromatography mass spectrometry (GC- cytosolic, both being encoded by the same gene located on MS) (according to Tanaka et al 1980) showed massive chromosome 1q.42.1 (Estevez et al 2002, Remes et al excretion of fumaric acid (> 232 mmol/ mol creatinine, 2004). They only differ at the aminoterminal residue: normal range < 45 mmol/mol creatinine). The same result pyroglutamic acid on the mitochondrial isoform and N- was presented by a new urine sample collected at 40 days acetylalanine on the cytosolic one (Akiba et al 1984). In of life. fumarase deficiency, both isoforms are affected. It is At 1 month of age, despite breast feeding and normal supposed that the cytosolic isoform processes fumaric acid sucking, the baby had extreme difficulty gaining weight, from the urea cycle, amino acid, and purine metabolism, remaining undernourished due to persistent vomiting and whereas the mitochondrial isoform originates from the occasional diarrhea. Cholestatic jaundice and hepatomegaly Krebs cycle (Lehtonen 2006). were noted since birth. At 40 days of life, the following The aim of this study was to report the first case of hepatic enzymes were altered: [aspartate aminotransferase fumaric aciduria in Brazil and to review data from patients (AST) 137 U/L, N 10–34 U/L; alanine aminotransferase found in the literature. (ALT) 78 U/L, N 5–35 U/L; alkaline leukocyte phosphatase (ALP) 267 U/L, N 20–140 U/L, and gamma- glutamyltranspeptidase (γ–GT) 505 U/L, N 0–51 U/L]. Case report Further exams at this period revealed colpocephaly [cranial computed tomography (CT)], infantile hypertrophic pyloric A girl, the fourth child of consanguineous parents (first stenosis [abdominal ultrasound (US)] and interatrial com- cousins), was born at 38 weeks of gestation after a munication (ECO). At one-and-a-half months of age, pregnancy complicated by polyhydramnios. Birth weight pyloromyotomy was performed, but vomiting episodes was 2180 g (< 3rd percentile), length 47 cm (∼10th persisted. At this time, she still presented with lactic percentile), head circumference 30 cm (< 3rd percentile), acidemia (5.0 µmol/ml), metabolic acidosis, and mild and APGAR score 8/9. One brother, born at term, and one hyperammonemia. Hemotransfusion was performed due to premature sister, had both died 6 h(presumed perinatal anemia. At 2 months and 4 days, hemoculture was positive asphyxia) and two days (cause not reported), respectively, for Staphylococcus epidermidis, and she was treated with after birth. Ultrasound images of the fourth child showed antibiotics for 14 days. There was a small weight gain, but agenesis of the corpus callosum and mild bilateral pyelo- hepatic enzymes remained altered. At 3 months and 5 days, caliceal dilatation. At physical examination, dysmorphic the girl was discharged but continued to gain weight slowly, features were noted, such as hypertelorism, overriding although being fed with breast milk and supplementary J Inherit Metab Dis (2010) 33:411–419 413 Table 1 Urinary and plasma amino acid analysis by ion-exchange chromatography of the patient here reported Amino acid Urine 1 (nmol/mg creatinine) Urine 2 (nmol/mg creatinine) Reference valuesa (0 - 1m) Plasma 1 Reference valuesa (nmol/mg creatinine) (nmol/ml) (0-1m) (nmol/ml) Threonine 10600 2262 124–1118 313 90–329 Serine 7350 3416 248–2898 263 99–395 Citrulline 5494 638 0–146 181 10–45 Methionine nd nd 104–875 70 10–60 Asparagine 4470 207 38–1373 99 29–132 Glutamine 5120 1540 81–923 430 376–709 Cystine 1359 1564 47–200 nd 17–98 Leucine 539 177.5 28–402 66 48–160 Tyrosine 3690 351.5 133–1490 257 55–147 Ornithine 1238 925.7 15–411 77 48–211 Lysine 3652 2683 218–1795 107 92–325 Histidine 6427 2467 365–2267 130 30–138 nd not detected a Metabolic Laboratory, Children’s Medical Center, Dallas, Texas, USA formula. Vomiting episodes twice a day and occasional dehydration. Besides hepatosplenomegaly,
Recommended publications
  • Hyperbranched Polyaspartate Esters and a Process for Their Preparation
    Europäisches Patentamt *EP000743335B1* (19) European Patent Office Office européen des brevets (11) EP 0 743 335 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) Int Cl.7: C08G 63/685 of the grant of the patent: 26.09.2001 Bulletin 2001/39 (21) Application number: 96107069.5 (22) Date of filing: 06.05.1996 (54) Hyperbranched polyaspartate esters and a process for their preparation Hyperverzweigte Polyaspartatester und Verfahren zu ihrer Herstellung Ester de polyaspartate hyperramifiés et procédé pour leur préparation (84) Designated Contracting States: (74) Representative: Pettrich, Klaus-Günter, Dr. AT BE CH DE ES FR GB IT LI NL SE c/o Bayer AG, Konzernbereich RP (30) Priority: 18.05.1995 US 443505 Patente und Lizenzen 51368 Leverkusen (DE) (43) Date of publication of application: 20.11.1996 Bulletin 1996/47 (56) References cited: US-A- 5 126 170 (73) Proprietor: Bayer Corporation Pittsburgh, PA 15205-9741 (US) • ISRA L JOURNAL OF CHEMISTRY, vol. 9, 1971, JERUSALEM, pages 105-109, XP000670606 A. (72) Inventors: SINGERMAN ET AL.: "Poly threo-beta-hydroxy • Yeske, Philip E. aspartic acid" Pittsburgh, PA 15228 (US) • Gindin, Lyuba K. Remarks: Pittsburgh, PA 15216 (US) The file contains technical information submitted • Wicks, Douglas A. after the application was filed and not included in this Mt. Lebanon, PA 15228 (US) specification • Jonsson, E. Haakan Coraopolis, PA 15108 (US) Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement.
    [Show full text]
  • Tbamitchodral L Alizaion of the 4Aminobutyrate-2-&Oxoglutarate
    5d.em. J. (lWg77) 161,9O.-307 3O1 Printed in Great Britain Tbamitchodral L alizaion of the 4Aminobutyrate-2-&Oxoglutarate Transminase from Ox Brait By INGER SCHOUSDOE,* BIRGIT 1MO* and ARNE SCHOUSBOEt Department ofBDahemistry At andC*, University ofCopenhagen, 2200 Copenhagen M, Denark (Receved 4 June 1976) In order to determine the intramitochondrial location of 4-aminobutyrate transaminase, mitochondria were prepared from ox brain and freed from myelin and syiaptosomes by using conventional demitygradient-centrifugation techniques, and the purity was checked electron-microscopically. Iner and outer mimbrenes and matrix were prepared from the mitochondria by large-amplitude sweling and subsequent density-gradient centrfugationt The fractions were characterized by using both electron microscopy and differnt marker enzymes. From the specific activity of the 4-aminobutyrate transaminase in the submitochondrial fractions it was concluded that this enzyme is associated with the inner mitochondrial membrane. It is generally agreed that the 4-aminobutyrate-2- pyridoxal phosphate were from Sigma Chemical oxoglutarate transaminase (EC2.6.1.19) from brain is Co., St. Louis, MO, U.S.A. Ficoll was from mainly associated with free mitochondria (Salganicoff Pharmacia, Uppsala, Sweden, and crystallized & De Robertis, 1963, 1965; van den Berget al., 1965; bovine serum albumin was from BDH Biochemicals, van Kempen et at., 1965; Balazs et al., 1966; Poole, Dorset, U.K. 4-Amino[1-'4C]butyrate (sp. Waksman et al., 1968; Reijnierse et al., 1975), radioactivity 50mCi/mmol) and [1-14qtyramine (sp. and a preparation of a crude mitochondrial fraction radioactivity 9mCi/mmol) were obtained from was used by Schousboe et al. (1973) and Maitre et al.
    [Show full text]
  • Alternative Acetate Production Pathways in Chlamydomonas Reinhardtii During Dark Anoxia and the Dominant Role of Chloroplasts in Fermentative Acetate Productionw
    This article is a Plant Cell Advance Online Publication. The date of its first appearance online is the official date of publication. The article has been edited and the authors have corrected proofs, but minor changes could be made before the final version is published. Posting this version online reduces the time to publication by several weeks. Alternative Acetate Production Pathways in Chlamydomonas reinhardtii during Dark Anoxia and the Dominant Role of Chloroplasts in Fermentative Acetate ProductionW Wenqiang Yang,a,1 Claudia Catalanotti,a Sarah D’Adamo,b Tyler M. Wittkopp,a,c Cheryl J. Ingram-Smith,d Luke Mackinder,a Tarryn E. Miller,b Adam L. Heuberger,e Graham Peers,f Kerry S. Smith,d Martin C. Jonikas,a Arthur R. Grossman,a and Matthew C. Posewitzb a Carnegie Institution for Science, Department of Plant Biology, Stanford, California 94305 b Colorado School of Mines, Department of Chemistry and Geochemistry, Golden, Colorado 80401 c Stanford University, Department of Biology, Stanford, California 94305 d Clemson University, Department of Genetics and Biochemistry, Clemson, South Carolina 29634 e Colorado State University, Proteomics and Metabolomics Facility, Fort Collins, Colorado 80523 f Colorado State University, Department of Biology, Fort Collins, Colorado 80523 ORCID ID: 0000-0001-5600-4076 (W.Y.) Chlamydomonas reinhardtii insertion mutants disrupted for genes encoding acetate kinases (EC 2.7.2.1) (ACK1 and ACK2) and a phosphate acetyltransferase (EC 2.3.1.8) (PAT2, but not PAT1) were isolated to characterize fermentative acetate production. ACK1 and PAT2 were localized to chloroplasts, while ACK2 and PAT1 were shown to be in mitochondria.
    [Show full text]
  • Comparison of Control Materials Containing Animal and Human Enzymes 579
    Gruber, Hundt, Klarweinf and Möllfering: Comparison of control materials containing animal and human enzymes 579 J. Clin. Chem. Clin. Biochem. Vol. 15,1977, pp. 579-582 Comparison of Control Materials Containing Animal and Human Enzymes Comparison of Enzymes of Human and Animal Origin, III By W. Gruber, D. Hundt, M. Klarweinf and A Mollering Boehringer Mannheim GmbH, Biochemica Werk Tutzing (Received February 7/May 31,1977) Summary: Highly purified enzymes of diagnostic interest from human and animal organs, dissolved in pooled human serum and in bovine serum albumin solution, were compared with respect to their response to alterations in routine clinical chemical assay conditions. Their response to changes in temperature, substrate concentration and pH-value was the same. In addition, the storage stability in each matrix was identical in the lyophilized and the reconstituted state, whereas some enzymes were remarkably less stable in the pooled human serum than in bovine serum albumin. This better stability, the better availability and decreased infectious nature of the material lead to the conclusion that animal enzymes in bovine serum albumin matrix are the material of choice for the quality control of enzyme activity determinations in clinical chemistry. Vergleichende Untersuchungen an Kontrollproben, aufgestockt mit tierischen und humanen Enzymen. Vergleich humaner und tierischer Enzyme, III. Mitteilung Zusammenfassung: Hoch gereinigte humane und tierische Enzyme von diagnostischem Interesse, gelöst in gepooltem Humanserum und in Rinderserumalbumin-Lösung wurden in Bezug auf ihr Verhalten gegenüber Änderungen der Reaktionsbedingungen bei klinisch-chemischen Routine-Methoden verglichen. Ihre Aktivitätsänderung bei Ver- änderung der Reaktionstemperatur, der Substrat-Konzentrationen und des pH-Wertes waren gleich.
    [Show full text]
  • Mutation of the Fumarase Gene in Two Siblings with Progressive Encephalopathy and Fumarase Deficiency T
    Mutation of the Fumarase Gene in Two Siblings with Progressive Encephalopathy and Fumarase Deficiency T. Bourgeron,* D. Chretien,* J. Poggi-Bach, S. Doonan,' D. Rabier,* P. Letouze,I A. Munnich,* A. R6tig,* P. Landneu,* and P. Rustin* *Unite de Recherches sur les Handicaps Genetiques de l'Enfant, INSERM U393, Departement de Pediatrie et Departement de Biochimie, H6pital des Enfants-Malades, 149, rue de Sevres, 75743 Paris Cedex 15, France; tDepartement de Pediatrie, Service de Neurologie et Laboratoire de Biochimie, Hopital du Kremlin-Bicetre, France; IFaculty ofScience, University ofEast-London, UK; and IService de Pediatrie, Hopital de Dreux, France Abstract chondrial enzyme (7). Human tissue fumarase is almost We report an inborn error of the tricarboxylic acid cycle, fu- equally distributed between the mitochondria, where the en- marase deficiency, in two siblings born to first cousin parents. zyme catalyzes the reversible hydration of fumarate to malate They presented with progressive encephalopathy, dystonia, as a part ofthe tricarboxylic acid cycle, and the cytosol, where it leucopenia, and neutropenia. Elevation oflactate in the cerebro- is involved in the metabolism of the fumarate released by the spinal fluid and high fumarate excretion in the urine led us to urea cycle. The two isoenzymes have quite homologous struc- investigate the activities of the respiratory chain and of the tures. In rat liver, they differ only by the acetylation of the Krebs cycle, and to finally identify fumarase deficiency in these NH2-terminal amino acid of the cytosolic form (8). In all spe- two children. The deficiency was profound and present in all cies investigated so far, the two isoenzymes have been found to tissues investigated, affecting the cytosolic and the mitochon- be encoded by a single gene (9,10).
    [Show full text]
  • Normalization of Γ-Glutamyl Transferase Levels Is Associated With
    Ma et al. BMC Gastroenterol (2021) 21:215 https://doi.org/10.1186/s12876-021-01790-w RESEARCH ARTICLE Open Access Normalization of γ-glutamyl transferase levels is associated with better metabolic control in individuals with nonalcoholic fatty liver disease Qianqian Ma1, Xianhua Liao1, Congxiang Shao1, Yansong Lin1, Tingfeng Wu1, Yanhong Sun2, Shi‑Ting Feng3, Junzhao Ye1* and Bihui Zhong1* Abstract Background: The normalization of liver biochemical parameters usually refects the histological response to treat‑ ment for nonalcoholic fatty liver disease (NAFLD). Researchers have not clearly determined whether diferent liver enzymes exhibit various metabolic changes during the follow‑up period in patients with NAFLD. Methods: We performed a retrospective analysis of patients with NAFLD who were receiving therapy from January 2011 to December 2019. Metabolism indexes, including glucose levels, lipid profles, uric acid levels and liver bio‑ chemical parameters, were measured. Magnetic resonance imaging‑based proton density fat fraction (MRI‑PDFF) and liver ultrasound were used to evaluate steatosis. All patients received recommendations for lifestyle modifcations and guideline‑recommended pharmacological treatments with indications for drug therapy for metabolic abnormalities. Results: Overall, 1048 patients with NAFLD were included and received lifestyle modifcation recommendations and pharmaceutical interventions, including 637 (60.7%) patients with abnormal GGT levels and 767 (73.2%) patients with abnormal ALT levels. Patients with concurrent ALT and GGT abnormalities presented higher levels of metabo‑ lism indexes and higher liver fat content than those in patients with single or no abnormalities. After 12 months of follow‑up, the cumulative normalization rate of GGT was considerably lower than that of ALT (38% vs.
    [Show full text]
  • Profiling Taste and Aroma Compound Metabolism During Apricot Fruit Development and Ripening
    Int. J. Mol. Sci. 2016, 17, 998; doi:10.3390/ijms17070998 S1 of S4 Supplementary Materials: Profiling Taste and Aroma Compound Metabolism during Apricot Fruit Development and Ripening Wanpeng Xi, Huiwen Zheng, Qiuyun Zhang and Wenhui Li Figure S1. Sugars HPLC chromatogram of apricot fruit. Peaks (1) Fructose (2) Glucose (3) Sucrose. (a) sugars mixture standards; (b) sugars for SG peel of S5; (c) sugars for SG pulp of S5. Int. J. Mol. Sci. 2016, 17, 998; doi:10.3390/ijms17070998 S2 of S4 Figure S2. Organic acids HPLC chromatogram of apricot fruit. Peaks (1) oxalic acid (2) tartaric acid (3) quininic acid (4) malic acid (5) citric acid (6) fumaric acid. (a) organic acids mixture standard; (b) organic acid for YC peel of S4; (c) organic acid for YC pulp of S4. Int. J. Mol. Sci. 2016, 17, 998; doi:10.3390/ijms17070998 S3 of S4 Table S1. Chroma values of apricot fruit during development and ripening. L* a* b* C* H Cultivars S1 S2 S3 S4 S5 S1 S2 S3 S4 S5 S1 S2 S3 S4 S5 S1 S2 S3 S4 S5 S1 S2 S3 S4 S5 DX 54.52 57.13 61.56 62.61 55.49 20.28 18.13 14.41 8.87 17.97 39.02 37.67 38.27 39.99 43.83 43.98 42.27 41.06 42.26 47.67 117.46 116.92 110.21 76.26 67.36 HY 54.97 55.83 61.53 65.08 65.11 −16.04 −14.77 −13.30 11.01 12.78 34.44 31.68 32.74 38.82 42.51 37.99 34.84 35.35 52.69 45.14 114.91 114.94 112.05 72.65 72.57 KE 47.02 47.00 48.32 60.11 60.66 −17.08 −17.37 −16.65 −0.36 8.20 30.83 29.09 29.08 48.23 48.48 35.26 33.88 33.51 48.33 49.33 118.94 120.86 119.85 90.67 118.02 AK 50.02 50.90 52.19 68.35 60.28 −21.98 −21.76 −19.02 -4.97 4.04 40.07 39.12 35.71
    [Show full text]
  • Anti-Inflammatory Role of Curcumin in LPS Treated A549 Cells at Global Proteome Level and on Mycobacterial Infection
    Anti-inflammatory Role of Curcumin in LPS Treated A549 cells at Global Proteome level and on Mycobacterial infection. Suchita Singh1,+, Rakesh Arya2,3,+, Rhishikesh R Bargaje1, Mrinal Kumar Das2,4, Subia Akram2, Hossain Md. Faruquee2,5, Rajendra Kumar Behera3, Ranjan Kumar Nanda2,*, Anurag Agrawal1 1Center of Excellence for Translational Research in Asthma and Lung Disease, CSIR- Institute of Genomics and Integrative Biology, New Delhi, 110025, India. 2Translational Health Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, 110067, India. 3School of Life Sciences, Sambalpur University, Jyoti Vihar, Sambalpur, Orissa, 768019, India. 4Department of Respiratory Sciences, #211, Maurice Shock Building, University of Leicester, LE1 9HN 5Department of Biotechnology and Genetic Engineering, Islamic University, Kushtia- 7003, Bangladesh. +Contributed equally for this work. S-1 70 G1 S 60 G2/M 50 40 30 % of cells 20 10 0 CURI LPSI LPSCUR Figure S1: Effect of curcumin and/or LPS treatment on A549 cell viability A549 cells were treated with curcumin (10 µM) and/or LPS or 1 µg/ml for the indicated times and after fixation were stained with propidium iodide and Annexin V-FITC. The DNA contents were determined by flow cytometry to calculate percentage of cells present in each phase of the cell cycle (G1, S and G2/M) using Flowing analysis software. S-2 Figure S2: Total proteins identified in all the three experiments and their distribution betwee curcumin and/or LPS treated conditions. The proteins showing differential expressions (log2 fold change≥2) in these experiments were presented in the venn diagram and certain number of proteins are common in all three experiments.
    [Show full text]
  • Citric Acid Cycle
    CHEM464 / Medh, J.D. The Citric Acid Cycle Citric Acid Cycle: Central Role in Catabolism • Stage II of catabolism involves the conversion of carbohydrates, fats and aminoacids into acetylCoA • In aerobic organisms, citric acid cycle makes up the final stage of catabolism when acetyl CoA is completely oxidized to CO2. • Also called Krebs cycle or tricarboxylic acid (TCA) cycle. • It is a central integrative pathway that harvests chemical energy from biological fuel in the form of electrons in NADH and FADH2 (oxidation is loss of electrons). • NADH and FADH2 transfer electrons via the electron transport chain to final electron acceptor, O2, to form H2O. Entry of Pyruvate into the TCA cycle • Pyruvate is formed in the cytosol as a product of glycolysis • For entry into the TCA cycle, it has to be converted to Acetyl CoA. • Oxidation of pyruvate to acetyl CoA is catalyzed by the pyruvate dehydrogenase complex in the mitochondria • Mitochondria consist of inner and outer membranes and the matrix • Enzymes of the PDH complex and the TCA cycle (except succinate dehydrogenase) are in the matrix • Pyruvate translocase is an antiporter present in the inner mitochondrial membrane that allows entry of a molecule of pyruvate in exchange for a hydroxide ion. 1 CHEM464 / Medh, J.D. The Citric Acid Cycle The Pyruvate Dehydrogenase (PDH) complex • The PDH complex consists of 3 enzymes. They are: pyruvate dehydrogenase (E1), Dihydrolipoyl transacetylase (E2) and dihydrolipoyl dehydrogenase (E3). • It has 5 cofactors: CoASH, NAD+, lipoamide, TPP and FAD. CoASH and NAD+ participate stoichiometrically in the reaction, the other 3 cofactors have catalytic functions.
    [Show full text]
  • Convergent Electron Transfer at the Q-Junction and Additive Effect of Substrate Combinations
    O2k-Protocols Mitochondrial Physiology Network 12.12: 1-13 (2012) 2007-2012 OROBOROS Version 6: 2012-11-04 Mitochondrial Pathways through Complexes I+II: Convergent Electron transfer at the Q-Junction and Additive Effect of Substrate Combinations Erich Gnaiger Medical University of Innsbruck D. Swarovski Research Laboratory 6020 Innsbruck, Austria OROBOROS INSTRUMENTS Corp, high-resolution respirometry Schöpfstr 18, A-6020 Innsbruck, Austria [email protected]; www.oroboros.at ‘It is not at all easy to draw a sharp line between cases where what is happening could be called “addition”, and where some other word is wanted.’ Douglas R. Hofstadter (1979) Gödel, Escher, Bach: An Eternal Golden Braid. A metaphorical fugue on minds and machines in the spirit of Lewis Carroll. Penguin Books. Section 1. Electron Transfer System and ET Chain 1 Page 2. Historical Perspectives 4 3. Pyruvate+Glutamate+Malate: PMG 9 4. Pyruvate+Malate+Succinate: PMS 9 5. Glutamate+Malate+Succinate: GMS 10 6. Pyruvate+Malate+Glutamate+Succinate: PMGS 11 7. Glycerophosphate Dehydrogenase and ETF 11 8. Implications 13 1. Electron Transfer System and ET Chain The term ‘electron transfer chain’ (or electron transport chain, ETC) is a misnomer. Understanding mitochondrial respiratory control has suffered greatly from this inappropriate terminology, although textbooks using the term ETC (Lehninger 1970; Nicholls & Ferguson 2002) make it sufficiently clear that electron transfer systems are not arranged as a chain: the ‘ETC’ is in fact not a simple chain but an arrangement of electron transfer complexes in a non-linear, convergent electron transfer system (Hatefi et al 1962; ETS; Fig. 1). [email protected] www.oroboros.at MiPNet12.12 MitoPathways to Complexes I+II 2 O2 Linear NADH CI CIII CIV ETC H2O GpDH CI Q-junction O2 Convergent Q ETS CII H2O ETF Figure 1.
    [Show full text]
  • Supplementary Table 1. Biochemical/Metabolic Disorders in ICEE; Clinical Features and Relevant Diagnostic Tests
    BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance Supplemental material placed on this supplemental material which has been supplied by the author(s) Arch Dis Child Educ Pract Ed Supplementary table 1. Biochemical/metabolic disorders in ICEE; clinical features and relevant diagnostic tests: Presentation Age of </> 1 year of Disorder group Disorder Sub disorder onset age Other features Treatable? Test Often infants born prem, sometimes family history of < 3 infertility & recurrent CSF pyridoxal Vitamin B6 PNPO months <1y miscarriage. Yes phosphate (UOA) Metabolic acidosis, electrolyte disturbance, abdominal distension, and feed intolerance, CSF pipecolate (pre- resulting in misdiagnosis as treatment); (urine Pyridoxine responsive < 3 hypoxic–ischaemic AASA where epilepsy months <1y encephalopathy or sepsis. Yes available) Failure to thrive & multisystem disease in early infancy; Congenital disorders of </> 3 hypotonia and seizures can glycosylation. Many subtypes months </> 1y be part of the clinical picture. most not Transferrin glycoforms Methylmalonic </> 3 Acute metabolic Organic acidurias acidurias months </> 1y decompensations. Yes UOA / acylcarnitines </> 3 Acute metabolic Propionic acidaemia months </> 1y decompensations. Yes UOA / acylcarnitines Developmental delay, hypotonia, dysmorphic D-2-hydroxyglutaric </> 3 features, often with aciduria months </> 1y cardiomyopathy. No UOA L-2-hydroxyglutaric > 3 aciduria months </> 1y Cerebellar dysfunction. Yes UOA Severe muscle weakness, respiratory distress Combined L and D < 3 syndrome, lack of 2OH-glutaric aciduria months <1y psychomotor development. No UOA Perry LD, et al. Arch Dis Child Educ Pract Ed 2021;0:1–8. doi: 10.1136/archdischild-2020-320606 BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance Supplemental material placed on this supplemental material which has been supplied by the author(s) Arch Dis Child Educ Pract Ed Supplementary table 1.
    [Show full text]
  • Table S1. Disease Classification and Disease-Reaction Association
    Table S1. Disease classification and disease-reaction association Disorder class Associated reactions cross Disease Ref[Goh check et al.
    [Show full text]